ConductScience.org, home

Paper3544786

Short- and long-term effects of calcium entry blockers on the kidney.

Bauer JH and 1 other. Am J Cardiol, 1987. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Short- and long-term effects of calcium entry blockers on the kidney. Papers, record 3544786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3544786

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Short- and long-term effects of calcium entry blockers on the kidney.
PubMed
Journal
Am J Cardiol
PubMed
Year
1987
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
5.32
iCite
Revised in PubMed
2019-06-22
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bauer JHJ H
2Reams GG

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcium Channel BlockersMajor topic
KidneyMajor topic
Animals
Body Fluids
Diuresis
Electrolytes
Humans
Renal Circulation
Renin-Angiotensin System
Time Factors

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
17154643A review of calcium channel antagonists in the treatment of pediatric hypertension.Paediatr Drugs2006https://conductscience.org/library/papers/17154643PubMed
8299661Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo.Eur J Clin Pharmacol1993https://conductscience.org/library/papers/8299661PubMed
7827397Do calcium channel blockers have renal protective effects?Drugs Aging1994https://conductscience.org/library/papers/7827397PubMed
7533695Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.Drugs1994https://conductscience.org/library/papers/7533695PubMed
7512464Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure.Drugs1993https://conductscience.org/library/papers/7512464PubMed
3154672Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive rat.Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/3154672PubMed
3154671Renal protective effects of calcium antagonists?Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/3154671PubMed
3154329Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154329PubMed
2856470Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/2856470PubMed
2657078Management of essential hypertension in the black patient: profiling as the initial approach to treatment.J Natl Med Assoc1989https://conductscience.org/library/papers/2657078PubMed
2278868Effects of calcium antagonists on the hypertensive kidney.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2278868PubMed
2150190Renal effects of the new calcium channel blocking drug isradipine.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2150190PubMed
2076410Renal effects of calcium entry blockers.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2076410PubMed
1989744Calcium-channel blockers and anaesthesia.Can J Anaesth1991https://conductscience.org/library/papers/1989744PubMed
1958437The effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1958437PubMed
1451221Treatment of intraoperative hypertension with enflurane, nicardipine, or human atrial natriuretic peptide: haemodynamic and renal effects.Can J Anaesth1992https://conductscience.org/library/papers/1451221PubMed
1283592Is renal protection with calcium antagonists possible?Drugs1992https://conductscience.org/library/papers/1283592PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3544786

GET https://conductscience.org/api/papers/v1/3544786/authors